IL2 and neoplasm: Exogenous IL‐2 induces T cell‐mediated anti‐tumor cytotoxicity.[56] IFN‐α has direct pro‐apoptotic activity on tumor cells and antiangiogenic activity, inhibiting tumor vasculature.[57] However, these cytokine therapies have adverse side effects on the immune system.